【摘 要】
：
Objectives: To review and evaluate the efficacy of Chinese Medicine in treating elderly with asthma.Methods: Elderly,asthma and Chinese Medicine were used as the key words to search in PubMed and Chin
【机 构】
：
School of Chinese Medicine, HKU
【出 处】
：
世界中医药学会联合会老年医学专业委员会第六届学术年会
论文部分内容阅读
Objectives: To review and evaluate the efficacy of Chinese Medicine in treating elderly with asthma.Methods: Elderly,asthma and Chinese Medicine were used as the key words to search in PubMed and Chinese National Knowledge Infrastructure retrieved from 1981 to 2017,and only randomized controlled trials with treatment groups treating by Chinese Medicine were included.Results: Results from five studies involving 533 patients shown that Chinese Medicine therapy (including Sanfu Tianjiu Therapy,Chinese medicine combined with rehabilitation therapy,Guben Pingchuan Decoction and other prescription of herbs for asthma,etc.) was more effective than the control intervention.All included studies were un-blinded which may resulting a high risk of bias.There were few adverse effects were reported in those studies.Conclusions: All studies indicated that Chinese Medicine has a positive effect on elderly with asthma.Since there were limitations of the trial design occurred in those studies resulted in high risk of bias,RCTs with better methodology are needed to further confirm the efficacy of Chinese Medicine therapy for elderly with asthma.
其他文献
The object of this study was to develop and validate a simple and reliable LC-MS/MS method for quantitation of erlotinib in human plasma.Methanol containing the isotope-labeled internal standard (erlo
Objective: A simple,sensitive,and selective liquid chromatography tandem mass spectrometry (LC-MS/MS) method was developed and validated for the simultaneous quantification of bosentan (BOS) and its m
目的：研究丹红注射液对大鼠脑缺血/再灌注损伤的治疗时间窗和作用机制。方法： (1)线栓法制备大鼠大脑中动脉阻断(Middle Cerebral Artery Occlusion,MCAO)模型,分别于缺血再灌注后1h、2h、4h、6h给予造模大鼠2ml/kg的丹红注射液,每隔24h给药一次,连续给药三天,以神经功能学评分、脑梗死面积、脑含水量以及血清神经元特异性烯醇酶为检测指标,评价丹红注射液对脑
A simple and sensitive UPLC-MS/MS method has been developed to simultaneous quantify ulipristal acetate (UPA) and its main active metabolite,N-desmethyl ulipristal acetate (N-UPA),in human plasma usin
目的：研究分心木水提物的中枢抑制作用的研究,为该药后续的保健品开发、镇静催眠的临床应用提供实验依据.方法：实验动物随机分为对照组,分心木0.5 g/kg组,分心木1g/kg组,分心木1.5g/kg组,按0.1 ml/10g灌胃给药.1.分心木与戊巴比妥钠45mg/kg的协同作用实验：给药一小时后,腹腔注射戊巴比妥钠45mg/kg,测定其睡眠潜伏期和入睡时间与对照组间的差异；2.分心木与戊巴比妥钠阈
目的：制首乌是一种常见的补益精血、乌须发、强筋骨、补肝肾的贵细中药材，虽然在中国药典和中药学没有记载何首乌有毒，但是随着何首乌在临床的应用越来越广泛，其不良反应报道也越来越多。包括何首乌在内的中药所谓“毒性”，往往是由“药之偏性”在一定条件下转化为“药之害”。何首乌的安全性问题往往是其制剂上市后在临床诊疗过程中，在临床功效表征的同时，因机体代谢产生某种肝毒性物质所致的肝损伤等不良反应，因而不良反应
目的：探究相关基因多态性对氯吡格雷代谢及缺血性脑卒中患者预后的影响,为患者个体化用药提供依据.方法：采用Sequenom MassARRAY SNP genotypeanalysis检测各基因多态性.二磷酸腺苷(ADP)诱导光比浊法测定缺血性脑卒中患者的血小板聚集功能.HPLC-MS/MS法检测氯吡格雷原药及活性代谢产物血药浓度.以主要不良心脑血管事件(MACCE)作为终点事件.运用SPSS21.
目的：建立并确证高效液相色谱-串联质谱法(UHPLC-MS/MS)测定人血浆中沙利度胺(Thalidomide,THD)浓度,并研究THD在克罗恩病患者中的药代动力学.方法：以伞形花内酯为内标,用BETASIL C18色谱柱(4.6 mm×150 mm,5μm),流动相为甲醇：0.1％甲酸水=70：30,样本经质谱APCI源正离子化后,用多反应离子监测方式对沙利度胺进行测定.以四个剂量组(每组N＞
目的：通过回顾性研究,探讨PPARA、PPP2R3C基因多态性及红细胞比容与肾移植术后早期患者体内他克莫司全血谷浓度的相关性,为个体化用药提供理论依据.方法：共纳入191例肾移植术后服用他克莫司+霉酚酸酯+糖皮质激素的患者,采用Agena Bioscience MassARRAY(R)system检测PPARA rs4253623,rs4823613及PPP2R3C rs2415259基因多态性,
目的：观察熄风化痰定眩汤对椎-基底动脉系统缺血性眩晕风痰上扰证患者的临床疗效.方法：以天津市第四中心医院中医科住院的椎-基底动脉系统缺血性眩晕风痰上扰证患者作为临床研究对象,将2013年8月至2016年1月间符合纳入标准的65例患者,应用SPSS17.0统计软件随机分为中药组(熄风化痰定眩汤组)34例,西药组(西比灵组)31例.中药组(熄风化痰定眩汤方主要药物：天麻159,钩藤109,菊花159,